Dermatological infection test kit PsorX-LabDisk

clinicallaboratorymolecular

At Dermagnostix, our team of leading dermatology researchers and clinicians is dedicated to pushing the boundaries of molecular diagnostics for dermatology. Discover the future of accurate diagnostics with PsorX-LabDisk (CE-IVD) as the first molecular test for the differential diagnosis of psoriasis and eczema. Revolutionize Psoriasis and Eczema Testing More Objectivity and Precision for Your Diagnostics Psoriasis and eczema are two of the most common inflammatory skin diseases, yet up to 50% of cases present diagnostic challenges1,2 due to significant overlap in both clinical and histopathologic features. This uncertainty complicates treatment, as modern therapies like biologicals and small-molecule inhibitors, tailored specifically for either psoriasis or eczema, may not reach their full potential and could even laggravate the disease in case of misdiagnosis. Traditional dermatological are based on subjective evaluation, which can result in misdiagnosis, and dissatisfied patients. Dermagnostix fills the diagnostic gap with its innovative PsorX-LabDisk (CE-IVD). It complements histopathological assessment by offering objective molecular diagnostics in dermatopathology, distinguishing psoriasis from eczema with high precision independent of individual users or their daily performance. Our technology enables the differential diagnosis between psoriasis and eczema, reducing uncertainty and guiding effective treatment. PsorX-LabDisk revolutionizes diagnostics – benefiting both patients and laboratory efficiency. Elevate your dermatopathology practice with molecular diagnostics – contact us today to learn more!